Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling

J Am Coll Cardiol. 2018 Dec 25;72(25):3370-3372. doi: 10.1016/j.jacc.2018.08.2202.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Aged
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / epidemiology
  • Drug Labeling / legislation & jurisprudence
  • Drug Labeling / trends*
  • Drug Prescriptions*
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*
  • Tertiary Care Centers / legislation & jurisprudence
  • Tertiary Care Centers / trends
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence
  • United States Food and Drug Administration / trends*

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors